{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:25:00Z","timestamp":1777386300444,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"the Northern Regional Operational Programme","award":["NORTE2020"],"award-info":[{"award-number":["NORTE2020"]}]},{"name":"the ERDF"},{"name":"Foundation for Science and Technology (FCT)"},{"name":"Institute of Biomedical Sciences Abel Salazar, University of Porto"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.etap.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T17:57:42Z","timestamp":1518803862000},"page":"24-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Cytotoxic activity of fucoxanthin, alone and in combination with the cancer drugs imatinib and doxorubicin, in CML cell lines"],"prefix":"10.1016","volume":"59","author":[{"given":"T\u00e2nia Patr\u00edcia","family":"Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Vettorazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Azqueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice Abreu","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2018.02.006_bib0005","doi-asserted-by":"crossref","first-page":"15054","DOI":"10.3390\/ijms131115054","article-title":"A review of molecular mechanisms of the anti-leukemic effects of phenolic compounds in honey","volume":"13","author":"Abubakar","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.etap.2018.02.006_bib0010","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s11095-008-9661-9","article-title":"Cancer is a preventable disease that requires major lifestyle changes","volume":"25","author":"Anand","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.etap.2018.02.006_bib0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/mutage\/get002","article-title":"Enhancing the sensitivity of the comet assay as a genotoxicity test, by combining it with bacterial repair enzyme FPG","volume":"28","author":"Azqueta","year":"2013","journal-title":"Mutagenesis"},{"key":"10.1016\/j.etap.2018.02.006_bib0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-3565(24)38772-5","article-title":"Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines","volume":"296","author":"Bellarosa","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2018.02.006_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/2040620712468289","article-title":"Management of imatinib-resistant patients with chronic myeloid leukemia","volume":"4","author":"Bhamidipati","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.etap.2018.02.006_bib0030","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/leu.2010.67","article-title":"BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia","volume":"24","author":"Burke","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.etap.2018.02.006_bib0035","first-page":"M4","article-title":"Biologically active compounds in seaweed extracts\u2014the prospects for the application","author":"Chojnacka","year":"2012","journal-title":"Open Conf. Proc. J."},{"key":"10.1016\/j.etap.2018.02.006_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-1161(75)90059-X","article-title":"Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells","volume":"31","author":"Clive","year":"1975","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2018.02.006_bib0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4490\/algae.2010.25.4.155","article-title":"Antioxidants from macroalgae: potential applications in human health and nutrition","volume":"25","author":"Cornish","year":"2010","journal-title":"Algae"},{"key":"10.1016\/j.etap.2018.02.006_bib0050","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.bcp.2008.02.004","article-title":"STI571\/doxorubicin concentration-dependent switch for diverse caspase actions in CML cell line K562","volume":"75","author":"Czyz","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2018.02.006_bib0055","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.etap.2018.02.006_bib0060","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.etap.2018.02.006_bib0065","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s10811-014-0287-5","article-title":"Seaweed biotechnology in Brazil: six decades of studies on natural products and their antibiotic and other biological activities","volume":"26","author":"Fernandes","year":"2014","journal-title":"J. Appl. Phycol."},{"key":"10.1016\/j.etap.2018.02.006_bib0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbagen.2011.02.008","article-title":"Siphonaxanthin, a marine carotenoid from green algae, effectively induces apoptosis in human leukemia (HL-60) cells","volume":"1810","author":"Ganesan","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.etap.2018.02.006_bib0075","first-page":"437","article-title":"Protective effect of black tea extract during chemotherapeutic drug induced oxidative damage on normal lymphocytes in comparison with cancerous K562 cells","volume":"5","author":"Ghosh","year":"2014","journal-title":"Int. J. Sci. Eng. Res."},{"key":"10.1016\/j.etap.2018.02.006_bib0080","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/imj.12135","article-title":"Leukaemias into the 21st century. Part 2: the chronic leukaemias","volume":"43","author":"Gibson","year":"2013","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.etap.2018.02.006_bib0085","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1182\/blood-2012-06-434894","article-title":"CaMKII gamma, a critical regulator of CML stem\/progenitor cells, is a target of the natural product berbamine","volume":"120","author":"Gu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.etap.2018.02.006_bib0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.redox.2013.12.020","article-title":"OpenComet: an automated tool for comet assay image analysis","volume":"2","author":"Gyori","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.etap.2018.02.006_bib0095","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/leu.2012.85","article-title":"Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)","volume":"26","author":"Hanfstein","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.etap.2018.02.006_bib0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/TCRM.S1527","article-title":"Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark)","volume":"4","author":"Henkes","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.etap.2018.02.006_bib0105","series-title":"Bioactive Compounds from Marine Foods: Plant and Animal Sources","author":"Hern\u00e1ndez-Ledesma","year":"2013"},{"key":"10.1016\/j.etap.2018.02.006_bib0110","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/ijc.23860","article-title":"Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol","volume":"123","author":"Ishikawa","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.etap.2018.02.006_bib0115","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.etap.2018.02.006_bib0120","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.tiv.2010.05.023","article-title":"Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway","volume":"24","author":"Kim","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.etap.2018.02.006_bib0125","first-page":"1","article-title":"Pharmacological importance of seaweeds: a review","volume":"6","author":"Kolanjinathan","year":"2014","journal-title":"World J. Fish Mar. Sci."},{"key":"10.1016\/j.etap.2018.02.006_bib0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1271\/bbb.69.224","article-title":"Characterization of apoptosis induced by fucoxanthin in human promyelocytic leukemia cells","volume":"69","author":"Kotake-Nara","year":"2005","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.etap.2018.02.006_bib0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jcb.20407","article-title":"Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells","volume":"95","author":"Kuzelova","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.etap.2018.02.006_bib0140","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0006-2952(00)00497-4","article-title":"Down-regulation of bcr-abl and bcl-x(L) expression in a leukemia cell line and its doxorubicin-resistant variant by topoisomerase II inhibitors","volume":"60","author":"Laroche-Clary","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2018.02.006_bib0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/ndt\/gfg564","article-title":"Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis","volume":"19","author":"Lebrecht","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.etap.2018.02.006_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cbi.2011.02.026","article-title":"Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway","volume":"190","author":"Liu","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.etap.2018.02.006_bib0155","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"Mahon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.etap.2018.02.006_bib0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.micres.2009.11.006","article-title":"Limitations in doxorubicin production from Streptomyces peucetius","volume":"165","author":"Malla","year":"2010","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.etap.2018.02.006_bib0165","doi-asserted-by":"crossref","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.etap.2018.02.006_bib0170","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/mp100455h","article-title":"Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells","volume":"8","author":"Misra","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.etap.2018.02.006_bib0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tifs.2011.09.001","article-title":"Seaweeds: a sustainable functional food for complementary and alternative therapy","volume":"23","author":"Mohamed","year":"2012","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.etap.2018.02.006_bib0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0145-2126(00)00125-9","article-title":"Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization","volume":"25","author":"Naumann","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.etap.2018.02.006_bib0185","doi-asserted-by":"crossref","first-page":"984","DOI":"10.6004\/jnccn.2009.0065","article-title":"NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia","volume":"7","author":"O\u2019Brien","year":"2009","journal-title":"J. Natl. Compr. Cancer Netw.: JNCCN"},{"key":"10.1016\/j.etap.2018.02.006_bib0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phytol.2015.09.007","article-title":"Bioactive compounds from brown seaweeds: phloroglucinol, fucoxanthin and fucoidan as promising therapeutic agents against breast cancer","volume":"14","author":"P\u00e1dua","year":"2015","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.etap.2018.02.006_bib0195","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbrc.2005.06.192","article-title":"Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis","volume":"334","author":"Park","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.etap.2018.02.006_bib0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0974-8490.171105","article-title":"Crude extracts of marine-derived and soil fungi of the genus neosartorya exhibit selective anticancer activity by inducing cell death in colon, breast and skin cancer cell lines","volume":"8","author":"Ramos","year":"2016","journal-title":"Pharmacogn. Res."},{"key":"10.1016\/j.etap.2018.02.006_bib0205","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.3390\/nu5124978","article-title":"Cancer preventive efficacy of marine carotenoid fucoxanthin: cell cycle arrest and apoptosis","volume":"5","author":"Rengarajan","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.etap.2018.02.006_bib0210","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.etap.2018.02.006_bib0215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1667\/RR3005","article-title":"The TP53 dependence of radiation-induced chromosome instability in human lymphoblastoid cells","volume":"159","author":"Schwartz","year":"2003","journal-title":"Radiat. Res."},{"key":"10.1016\/j.etap.2018.02.006_bib0220","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1038\/sj.onc.1206087","article-title":"BCR\/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability","volume":"21","author":"Skorski","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.etap.2018.02.006_bib0225","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.etap.2018.02.006_bib0230","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/md10092055","article-title":"In vivo induction of apoptosis by fucoxanthin, a marine carotenoid, associated with down-regulating STAT3\/EGFR signaling in sarcoma 180 (S180) xenografts-bearing mice","volume":"10","author":"Wang","year":"2012","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.etap.2018.02.006_bib0235","first-page":"1926","article-title":"Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein","volume":"9","author":"Watanabe","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.etap.2018.02.006_bib0240","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1182\/blood-2004-04-1433","article-title":"Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein","volume":"104","author":"Yin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.etap.2018.02.006_bib0245","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/leu.2008.74","article-title":"Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism","volume":"22","author":"Zhang","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.etap.2018.02.006_bib0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","article-title":"Leukemia stem cells: the root of chronic myeloid leukemia","volume":"6","author":"Zhou","year":"2015","journal-title":"Protein Cell"}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668918300310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668918300310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:57:32Z","timestamp":1751407052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668918300310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":50,"alternative-id":["S1382668918300310"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2018.02.006","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxic activity of fucoxanthin, alone and in combination with the cancer drugs imatinib and doxorubicin, in CML cell lines","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}